# Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer

> **NCT01442974** · NA · COMPLETED · sponsor: **Grupo Hospital de Madrid** · enrollment: 15 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** Gemcitabine plus nab-paclitaxel

## Key facts

- **NCT ID:** NCT01442974
- **Lead sponsor:** Grupo Hospital de Madrid
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-01
- **Final completion:** 2012-06
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2013-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01442974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01442974, "Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01442974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*